Skip to main content
Advertisement
Advertisement

XBIO

XBIO logo

Xenetic Biosciences, Inc.

2.47
USD
Sponsored
-0.05
-1.98%
Sep 24, 15:57 UTC -4
Closed
exchange

Pre-Market

2.45

-0.02
-0.69%

XBIO Earnings Reports

Positive Surprise Ratio

XBIO beat 15 of 26 last estimates.

58%

Next Report

Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
--

Xenetic Biosciences, Inc. earnings per share and revenue

On Aug 10, 2026, XBIO reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q3 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Xenetic Biosciences, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Nov 10, 2026.
Based on -- analysts, Xenetic Biosciences, Inc. is expected to report EPS of -- and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement